Dexamethasone Intravitreal Implant (Ozurdex) in Paediatric Patients with Non-infectious Intermediate Uveitis and Related Cystoid Macular Oedema: Evaluation of Macular Morphology and Function with Six-month Follow-up; a Deeper Role of MfERG?

References

• Tomkins-Netzer O, Taylor SR, Lightman S. Corticosteroid-sparing agents: new treatment options. Dev Ophthalmol. 2012;51:47–56.
   PubMedGoogle Scholar
• McDonough AK, Curtis JR. SaagKG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20(2):131–137. doi:https://doi.org/10.1097/BOR.0b013e3282f51031.
   PubMed Web of Science ®Google Scholar
• Haller JA, Bandello F, Belfort R Jr, et al. Ozurdex GENEVA Study Group; Randomized, sham controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117:1134–1146. doi:https://doi.org/10.1016/j.ophtha.2010.03.032.
   PubMed Web of Science ®Google Scholar
• Kuppermann BD, Blumenkranz MS, Haller JA, et al. Dexamethasone DDS Phase II Study Group: randomized control study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125:309–317. doi:https://doi.org/10.1001/archopht.125.3.309.
   PubMed Web of Science ®Google Scholar
• Williams GA, Haller JA, Kuppermann BD, et al. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol. 2009;147:1048–1054. doi:https://doi.org/10.1016/j.ajo.2008.12.033.
   PubMed Web of Science ®Google Scholar
• Ghosn CR, Li Y, Orilla WC, et al. Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci. 2001;52:2917–2923. doi:https://doi.org/10.1167/iovs.10-5939.
   Google Scholar
• Taylor SRJ, Tomkins-Netzer O, Joshi L, Morarji J, McLoone E, Lightman S. Dexamethasone implant in pediatric uveitis. Ophthalmology. 2012;119:2412–2412 e2. doi:https://doi.org/10.1016/j.ophtha.2012.07.025.
   PubMed Web of Science ®Google Scholar
• Sella R, Oray M, Frilling R, Umar L, Tugal-Tutkun I, Kramer M. Dexamethasone intravitreal implant (Ozurdex) for pediatric uveitis. Graefes Arch Exp Ophthalmol. 2015;253:1777–1782. doi:https://doi.org/10.1007/s00417-015-3124-x.
   PubMed Web of Science ®Google Scholar
• Tomkins-Netzer O, Lightman S, Drye L, et al. Outcome of treatment of uveitic macular edema. The multicenter uveitis steroid treatment trial 2-year results. Ophthalmology. 2015;122(11):2351–2359. doi:https://doi.org/10.1016/j.ophtha.2015.07.036.
   PubMed Web of Science ®Google Scholar
• Tomkin-Netzer O, Lazha T, Seguin-Greenstein S, Bar A, Lightman S. Outcome of treating pediatric uveitis with dexamethasone implants. Am J Ophthalmol. 2015;161:110–115. doi:https://doi.org/10.1016/j.ajo.2015.09.036.
   PubMed Web of Science ®Google Scholar
• Yap CY, Papathomas T, Kamal A. Results of intravitreal dexamethasone implant 0.7 mg (Ozurdex) in non-infectious posterior uveitis. Int J Ophthalmol. 2015;8:835–838. doi:https://doi.org/10.3980/j..2222-3959.2015.04.34.
   PubMed Web of Science ®Google Scholar
• Palia S, Biswas J, Nagesha CK. Efficacy of Ozurdex implant in treatment of non-infectious intermediate uveitis. Indian J Ophthalmol. 2015;63(10):767–770. doi:https://doi.org/10.4103/0301-4738.171505.
   PubMed Web of Science ®Google Scholar
• Tsang AC, Virgili G, Abtahi M, Gottlieb CC. Intravitreal dexamethasone implant for the treatment of macular edema in chronic non-infectious uveitis. Ocul Immunol Inflamm. 2016;18:1–8.
   Google Scholar
• Iijima H. Mechanisms of vision loss in eyes with macular edema associated with retinal vein occlusion. Jpn J Ophthalmol. 2018;62:265–273. doi:https://doi.org/10.1007/s10384-018-0586-5.
   PubMed Web of Science ®Google Scholar
• Buzzonetti L, Petroni S, Catena G, Iarossi G. Optical coherence tomography and electrophysiological findings in torpedo maculopathy. Doc Ophthalmol. 2015;130:65–70. doi:https://doi.org/10.1007/s10633-014-9472-8.
   PubMed Web of Science ®Google Scholar
• Hood DC, Bach M, Brigell M, et al. ISCEV Standard for clinical multifocal electroretinography (2011 edition). Doc Ophthalmol. 2012;124:1–13. doi:https://doi.org/10.1007/s10633-011-9296-8.
   PubMed Web of Science ®Google Scholar
• Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. Standard for clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69–77. doi:https://doi.org/10.1007/s10633-008-9155-4.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92(4):467–471. doi:https://doi.org/10.1016/S0161-6420(85)34001-0.
   PubMed Web of Science ®Google Scholar
• Lowder C, Belfort R Jh, Lightman S, et al. Dexamethasone intravitreal implant for non-infectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129:545–553. doi:https://doi.org/10.1001/archophthalmol.2010.339.
   PubMed Web of Science ®Google Scholar
• Haller JA, Bandello F, Belfort R Jh, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results. Ophthalmology. 2011;118:2453–2460. doi:https://doi.org/10.1016/j.ophtha.2011.05.014.
   PubMed Web of Science ®Google Scholar
• Querques G, Lattanzio R, Querques L, et al. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function. Retina. 2014;34(2):330–341.
   PubMed Web of Science ®Google Scholar
• Yasuda S, Kachi S, Ueno S, Piao CH, Terasaki H. Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion. Acta Ophthalmol. 2015;93:465–468. doi:https://doi.org/10.1111/aos.12674.
   Web of Science ®Google Scholar
• Catier A, Tadayoni R, Paques M, et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol. 2005;140(2):200–206. doi:https://doi.org/10.1016/j.ajo.2005.02.053.
   PubMed Web of Science ®Google Scholar
• Chhablani JK, Bartsch DU, Freeman W. Association between the macular volume and visual acuity was found to be weak. Retina. 2011; author reply 815-6 31:(4):815. doi:https://doi.org/10.1097/IAE.0b013e31820e8d96.
   PubMedGoogle Scholar
• Blumenkranz MS, Haller JA, Kuppermann BD, et al. Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina. 2010;30(7):1090–1094. doi:https://doi.org/10.1097/IAE.0b013e3181dcfaf3.
   PubMed Web of Science ®Google Scholar
• Ou WC, Brown DM, Payne JF, Wykoff CC. Relationship between visual acuity and retinal thickness during anti-vascular endothelial growth factor therapy for retinal diseases. Am J Ophthalmol. 2017;180:8–17. doi:https://doi.org/10.1016/j.ajo.2017.05.014.
   PubMed Web of Science ®Google Scholar